Avocet Bio, Shielding the World Against Current and Future Viral Threats
At Avocet Bio, we are reshaping the landscape of global health, empowering our mission with pioneering technology. Our solution offers a broad-spectrum approach capable of mitigating potential pandemics with an immediate "plug and act" execution.
How it works
Upon infection with an RNA virus, the viral genome is released into the cell, where it is amplified, and its transcripts translated into proteins to form additional copies of the virus.
CRISPR/Cas13 enzymes cleave different sites of the viral genome and its transcripts guided through a combination of virus specific crRNAs. Proliferation of the virus is blocked, and transcription of viral toxic proteins is reduced.
Our platform technology
